New Vicaplus Tablet 5/20/12.5 Milligrams

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5mg: To be administered to patients whose blood pressure is not adequately controlled with combined treatment of Amlodipine and Olmesartan Medoxomil 5/20mg. - 5/40/12.5mg: To be administered to those inadequately controlled by Amlodipine/Olmesartan Medoxomil 5/40.

Child dose

The safety and efficacy of this medication for pediatric patients under 18 years have not been established, thus administration is not recommended.

This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, or those with certain heart, kidney, or liver diseases should not use it. Patients with very low blood pressure, severe heart failure, or significantly impaired kidney function may also be at risk when taking this medication. Patients with low blood volume or insufficient body salt may experience hypotensive symptoms when first taking it, so caution is necessary. Patients with weakened kidney function or kidney transplant recipients should have regular blood tests to monitor their kidney function and electrolyte status. Patients with liver dysfunction or liver disease may experience serious side effects such as hepatic coma when taking this medication and should be cautious. Elderly patients or those with certain diseases may respond more sensitively to this medication, so consultation with a physician before use is advised. This medication may interact with other antihypertensives or specific medications, so it should be taken after consultation with a healthcare professional. Symptoms such as dizziness, headache, and swelling may occur during treatment; in severe cases, immediate medical attention should be sought. This medication is not recommended for lactating women; it is advisable to avoid taking it or to cease breastfeeding during treatment. It is safe for children under 18 years not to take this medication. In cases of overdose, severe hypotension or heart problems may occur, so the prescribed dosage and administration should be strictly followed. This medication should be stored in a tightly sealed container away from direct sunlight and moisture, out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, high fever accompanied by severe rash, blisters, skin peeling, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, abnormal respiratory symptoms accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme body lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, numbness, urination disorders

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1°C and 30°C.

Appearance

White and orange round film-coated tablet

Package unit

30 tablets/PPT[10 tablets/Alu-Alu×3]